Logo

Fitbit to Launch ECG App in the US and EU in October 2020

Share this
Fitbit to Launch ECG App in the US and EU in October 2020

Fitbit to Launch ECG App in the US and EU in October 2020

Shots:

  • Fitbit’s ECG app has received the US FDA’s 510 (k) clearance and EC’s CE marking to assess heart rhythm for atrial fibrillation (AFib). The ECG app will be available in Oct’2020 to the users on the Fitbit Sense smartwatch
  • The company has launched a multi-site clinical trial across the US- to detect AFib from normal sinus rhythm and to generate an ECG trace- recording of a heart’s electrical rhythm- that is qualitatively like Lead I ECG. The study demonstrated that the algorithm has an ability to detect 98.7% of AFib cases (sensitivity) and is 100% accurate in identifying study participants with normal sinus rhythm (specificity)
  • Fitbit Sense smartwatch is available today for pre-order on Fitbit.com with WW availability starting later this month and is available for $329.95 in carbon/graphite stainless steel and lunar white/soft gold stainless steel

­ Ref: Fitbit | Image: Fitbit

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions